Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
79.45
+0.79 (1.00%)
Mar 4, 2026, 4:00 PM EST - Market closed
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 22 analysts with 12-month price forecasts for Ionis Pharmaceuticals stock have an average target of 85.91, with a low estimate of 39 and a high estimate of 110. The average target predicts an increase of 8.13% from the current stock price of 79.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ionis Pharmaceuticals stock from 22 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 8 | 8 | 9 | 9 | 9 | 9 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $102 → $104 | Buy | Maintains | $102 → $104 | +30.90% | Mar 3, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $87 → $100 | Buy | Maintains | $87 → $100 | +25.87% | Feb 27, 2026 |
| Stifel | Stifel | Hold Maintains $73 → $77 | Hold | Maintains | $73 → $77 | -3.08% | Feb 26, 2026 |
| Needham | Needham | Strong Buy Maintains $90 → $103 | Strong Buy | Maintains | $90 → $103 | +29.64% | Feb 26, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $77 → $87 | Buy | Maintains | $77 → $87 | +9.50% | Feb 6, 2026 |
Financial Forecast
Revenue This Year
852.60M
from 943.71M
Decreased by -9.65%
Revenue Next Year
1.42B
from 852.60M
Increased by 66.43%
EPS This Year
-3.88
from -2.38
EPS Next Year
-1.50
from -3.88
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.0B | 2.1B | |||
| Avg | 852.6M | 1.4B | |||
| Low | 673.1M | 970.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 8.7% | 144.0% | |||
| Avg | -9.7% | 66.4% | |||
| Low | -28.7% | 13.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.89 | 2.10 | |||
| Avg | -3.88 | -1.50 | |||
| Low | -4.60 | -3.88 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.